A Randomized Controlled Trial of Open Surgical vs. Rapid, Minimally-invasive Voluntary Adult Male Circumcision

September 4, 2018 updated by: Peter Millard, Simunye Primary Health Care
To identify a minimally-invasive surgical circumcision technique for men, which is easy to learn and perform, is safe, and is associated with high patient satisfaction and excellent cosmetic results.

Study Overview

Detailed Description

Voluntary medical male circumcision (VMMC) is a priority preventive intervention for HIV transmission. Currently, the most widely used VMMC technique in South Africa is open surgical circumcision.

According to the Framework for Clinical Evaluation of Devices for Adult Male Circumcision (WHO, 2011): "WHO and other health authorities wish to identify one or more devices that (a) would make the VMMC safer, easier, and quicker; (b) would have more rapid healing than current methods and/or might entail less risk of HIV transmission in the post-operative period; (c) could be performed safely by health-care providers with a minimal level of training; and (d) would be cost-effective compared to standard surgical methods for male circumcision scale up."

This randomized controlled trial compares the open surgical technique to an alternative minimally-invasive technique using a disposable Unicirc device with tissue adhesive. The investigators postulate that VMMC using the Unicirc device meets WHO criteria for the ideal method to scale up: it is an easier technique to learn and perform, requires less intraoperative time, is safer for both surgeons and patients, heals quicker, and is more cost effective than other currently available techniques. The disposable nature of the device is an immense advantage as it eliminates the need to sterilize and can therefore be used in resource-limited settings. It also reduces the chances of infection caused by contaminated instruments.

The study will randomly assign participants to one of two groups:

  • Unicirc device with tissue adhesive: 100 men
  • Open surgical circumcision: 50 men

The participants will be evaluated during follow-up visits at 2 days, 7 days, 14 days, and 28 days after surgery.

Study Type

Interventional

Enrollment (Actual)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Western Cape
      • Mitchells Plain, Western Cape, South Africa
        • Simunye Primary Healthcare

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Healthy men at least 18 years of age requesting circumcision
  • No anatomical penile abnormalities or infections
  • Able to provide informed consent to participate
  • Willing to participate in follow-up visits

Exclusion Criteria:

  • Current illness
  • Penile abnormality or infection which contraindicates or would complicate circumcision
  • History of bleeding disorder
  • Past reaction to local anesthetic

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Open surgical circumcision
The open surgical technique, which is commonly used for circumcision in South Africa, requires good surgical skills and minor complications are common.
Open surgical circumcision using a technique approved by the WHO (dorsal slit)
Experimental: Unicirc device with tissue adhesive
Coupling removal of the foreskin using the disposable Unicirc device with wound sealing using tissue adhesive results in a procedure that can be performed by generalist doctors with minimal training.
Removal of foreskin with Unicirc disposal device and wound sealing with tissue adhesive.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative Duration
Time Frame: 1 hour
Amount of time from first manipulation of tissue under local anesthesia to dressing
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difficulty in Learning and Performing Technique
Time Frame: 1 year

Evaluated by doctor survey based on 5 point Likert scale

  1. Unicirc is much easier
  2. Unicirc is easier
  3. Neutral
  4. Open surgical is easier
  5. Open surgical is much easier
1 year
Number of Participants With Complete Wound Healing by Post-Surgery Week 4
Time Frame: Within 4 weeks after surgery
Within 4 weeks after surgery
Pain Experienced
Time Frame: Within 2 days after surgery
Pain experienced during and after the procedure evaluated using a 10 point pain scale (0 signifies no pain and 10 signifies maximal pain
Within 2 days after surgery
Overall Patient Satisfaction
Time Frame: Within 6 weeks after surgery

Patient satisfaction evaluated with questionnaire using satisfaction scale

  1. Very satisfied
  2. Satisfied
  3. Not satisfied
Within 6 weeks after surgery
Cosmetic Result
Time Frame: Within 6 weeks after surgery
Cosmetic result evaluated by classification of scar line as regular (straight without any irregularity), irregular (not completely straight), or scalloped (with a wavy appearance)
Within 6 weeks after surgery

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Adverse Events
Time Frame: 1 year
Number of participants with intraoperative and post-operative adverse events, such as bleeding, hematoma, and infection
1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Peter S Millard, MD, PhD, Simunye Primary Health Care

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2013

Primary Completion (Actual)

August 1, 2013

Study Completion (Actual)

August 1, 2013

Study Registration Dates

First Submitted

June 11, 2013

First Submitted That Met QC Criteria

June 12, 2013

First Posted (Estimate)

June 13, 2013

Study Record Updates

Last Update Posted (Actual)

October 2, 2018

Last Update Submitted That Met QC Criteria

September 4, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Circumcision

Clinical Trials on Open surgical circumcision

Subscribe